Continuation of Development Clause Samples

The "Continuation of Development" clause defines the parties' rights and obligations regarding the ongoing progress of a project or product after a specific event, such as a change in ownership, termination, or a milestone. Typically, this clause outlines the conditions under which development activities may continue, who retains control or access to project materials, and any requirements for transferring work-in-progress. Its core practical function is to ensure that development efforts are not unduly interrupted and that both parties understand how ongoing work will be managed, thereby minimizing disputes and maintaining project momentum.
POPULAR SAMPLE Copied 1 times
Continuation of Development. (A) If Developer has obtained 15 sites that have been approved for development by Atria prior to the end of the Development Term, Developer may continue to locate sites (the "Additional Sites") during the balance of the Development Term for development in the Southeast Region which, if approved by Atria, shall become subject to the terms of this Agreement. If after 15 sites have been approved Atria refuses to approve three Additional Sites that Developer submitted to Atria, and Atria fails to provide an alternate site acceptable in each of four "Metropolitan Areas" (as defined by the Office of Management and Budget), then either party may terminate this Agreement solely with respect to future development. Notwithstanding termination of this Agreement pursuant to this Section 1.3(a), if Atria desires to develop a site located within the Southeast Region at anytime prior to the third anniversary of this Agreement, then Atria shall permit Developer to develop the site located therein on the same terms and conditions set forth in this Agreement as though the termination had not occurred. (B) If during the Development Term and following approval of at least 15 sites, Atria refuses to approve three Additional Sites in any Metropolitan Area and fails to provide an alternative site located within such Metropolitan Area acceptable to Developer within 90 days of the date that Atria rejects the third Additional Site, then Developer may terminate this Agreement as to that Metropolitan Area; provided, however, that if Atria decides to enter into such Metropolitan Area within 12 months following the date that Developer terminated this Agreement as to that Metropolitan Area, then Atria shall permit Developer to develop the site located therein on the same terms and conditions set forth in this Agreement as though the termination had not occurred. Any termination under this Section 1.3(b) may be made on behalf of Developer solely by Assisted Care Developers, l.l.c., a Georgia limited liability company ("Assisted Care") and a member of Developer, without the consent of Atria. (C) All of the parties' rights and obligations regarding existing sites that have been approved by Atria and existing Assisted Living Facilities under construction or operation prior to the termination of this Agreement pursuant to this Section 1.3 shall remain in full force and effect.
View Source
Continuation of Development. If Selecta notified Spark in writing that it or its relevant Affiliate intends to continue the Development or Commercialization of the Competing Product as provided in Section 2.7(a) (Options), such Development or Commercialization of such Competing Product will not be a breach of Section 2.6 (Exclusivity) for so long as Selecta or its relevant Affiliate does not use of any Know-How or practice any Patent, in each case, Controlled by Selecta or any of its Affiliates prior to the consummation of the Acquisition.
View SourceView Similar (3)
Continuation of Development. 4 Atria's Right To Develop in the Southeast Region.................... 2
View Source
Continuation of Development of Indications that do not Meet Go Criteria. No Party may continue a Clinical Trial program for a new line of therapy being developed for a Final Product in Japan pursuant to the Long-Term Development Plan for which one or more pertinent go/no-go studies set forth in the Long-Term Development Plan for such new line of therapy have not met specific go criteria that either are set forth in the Long-Term Development Plan or have otherwise been agreed to in writing by BMS/BMKK and Merck/MJ, without the prior written consent of the other Parties (to be given or withheld in such Party’s sole discretion).
View Source
Continuation of Development. A new Section 2.6 of the Agreement is hereby added as follows : “If GSK suspends development of a GSK Antibody, is contractually obligated to provide […***…]45 with any information necessary to enable […***…]46 of such GSK Antibody, and demonstrates such contractual obligation to Zymeworks, Zymeworks shall use commercially reasonably efforts to […***…]”47
View Source

Related to Continuation of Development

  • Continuation of Work Pending the resolution of any dispute or claim pursuant to this Article 11, the Parties agree that performance of all obligations will be pursued diligently.

  • Continuation of Agreement This Agreement shall become effective for each Fund as of the date first set forth above and shall continue in effect for each Fund until August 1, 2010, unless sooner terminated as hereinafter provided, and shall continue in effect from year to year thereafter for each Fund only as long as such continuance is specifically approved at least annually (i) by either the Board of Directors or by the vote of a majority of the outstanding voting securities of such Fund, and (ii) by the vote of a majority of the Directors, who are not parties to the Agreement or interested persons of any such party, cast in person at a meeting called for the purpose of voting on such approval. The annual approvals provided for herein shall be effective to continue this Agreement from year to year if given within a period beginning not more than 90 days prior to August 1st of each applicable year, notwithstanding the fact that more than 365 days may have elapsed since the date on which such approval was last given.

  • CONTINUATION OF COMPANY In the event of an occurrence described in Section 1.04, if there is at least (1) one remaining Member, the remaining Member has the right to continue the business of the Company. The remaining Member’s successor, assignee, or transferee may continue the business of the Company, provided the successor, assignee, or transferee consents to the continuation in writing and submits any necessary filings to the office of the Secretary of State.

  • Continuation of Services The Contractor shall work with the current Subcontractor prior to cancellation date to ensure all consumer needs are identified and appropriate placements and transportation needs, as applicable, have been arranged. The Subcontractor shall maintain communication with the Contractor on the process of transferring consumers until all consumers are placed.

  • Continuation of Terms Upon any reorganization, consolidation, merger or transfer (and any dissolution following any transfer) referred to in this Section 3, this Warrant shall continue in full force and effect and the terms hereof shall be applicable to the Other Securities and property receivable on the exercise of this Warrant after the consummation of such reorganization, consolidation or merger or the effective date of dissolution following any such transfer, as the case may be, and shall be binding upon the issuer of any Other Securities, including, in the case of any such transfer, the person acquiring all or substantially all of the properties or assets of the Company, whether or not such person shall have expressly assumed the terms of this Warrant as provided in Section 4. In the event this Warrant does not continue in full force and effect after the consummation of the transaction described in this Section 3, then only in such event will the Company's securities and property (including cash, where applicable) receivable by the Holder of the Warrants be delivered to the Trustee as contemplated by Section 3.2.